Table 2 Microbiology and treatment parameters
Inappropriate (n = 80) | Appropriate (n = 10) | P value | |
|---|---|---|---|
Microbiology* | |||
C. albicans | 53 (66.3%) | 5 (50.0%) | 0.319 |
C. glabrata | 13 (16.3%) | 2 (20.0%) | 0.671 |
C. parapsillosis | 8 (10.0%) | 2 (20.0%) | 0.307 |
C. tropicalis | 4 (5.0%) | 1 (10.0%) | 0.453 |
C. kruzei | 2 (2.5%) | 0 | 1.000 |
C. lucitaniae | 1 (1.3%) | 0 | 1.000 |
Fluconazole susceptible | 63 (78.8%) | 8 (80.0%) | 1.000 |
Antifungal treatment¶ | |||
Fluconazole | 42 (52.5%) | 6 (60.0%) | 1.000 |
Caspofungin | 35 (43.8%) | 4 (40.0%) | |
Amphotericin B | 2 (2.5%) | 0 | |
Voriconazole | 1 (1.3%) | 0 | |
Antifungal delayed 24+ hours | 76 (95.0%) | 0 | <0.001 |
Inappropriate dose | 21 (26.3%) | 0 | 0.109 |
CVC removed | 58 (82.9%) | 6 (75.0%) | 0.629 |